Trademark Overview
On Wednesday, November 15, 2023, a trademark application was filed for EPIBONE with the United States Patent and Trademark Office. The USPTO has given the EPIBONE trademark a serial number of 98271977. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 8, 2024. This trademark is owned by EpiBone, Inc.. The EPIBONE trademark is filed in the Pharmaceutical Products category with the following description:
Biological tissues, namely, grafts for medical or clinical purposes; Biological tissues, namely, living bone grafts engineered from mesenchymal stem cells for bone graft implantations in humans; Bone growth media consisting of biological materials for medical and clinical use; Cultured human mesenchymal stem cells for therapeutic bone graft use; Pharmaceutical and biological preparations for use in humans for the treatment of bone defects; Human cells and biological tissue cultures intended for subsequent implantation for medical or clinical use; Cells for medical or clinical use; Cultured human bone cells for therapeutic use; Living biological tissue grown and regenerated ex vivo for subsequent implantation in vivo, namely, engineered living bone tissue; and Biological implants, namely, vital processed human or animal tissue in the nature of a 3D tissue scaffold to be implanted in vivo, and replacement of bone tissues
